00858.HK
Extrawell Pharmaceutical Holdings Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · HK
HKD 0.04
−13.73%Year over year
Reported trailing growth
- Revenue
- -7.1%
- EBITDA
- —
- EBIT
- +6.5%
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- -53.4%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -10.8%
- EBITDA
- —
- EBIT
- -9.1%
- Net income
- —
- EPS
- —
- Free cash flow
- +100.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026